methylprednisolone has been researched along with Cancer of Paranasal Sinus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garrott, H; O'Day, J | 1 |
Claes, J; Cras, P; De Raeve, H; De Ridder, D; Parizel, PM; Van Diest, D | 1 |
Kastenbauer, E; Kramer, MF; Ostertag, P; Rasp, G | 1 |
1 trial(s) available for methylprednisolone and Cancer of Paranasal Sinus
Article | Year |
---|---|
[A new system for the classification of ethmoid polyposis. Effect of combined local and systemic steroid therapy].
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Budesonide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Ethmoid Sinus; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Nasal Polyps; Neoplasm Staging; Paranasal Sinus Neoplasms | 2000 |
2 other study(ies) available for methylprednisolone and Cancer of Paranasal Sinus
Article | Year |
---|---|
Optic neuropathy secondary to radiotherapy for nasal melanoma.
Topics: Aged; Anticoagulants; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Melanoma; Methylprednisolone; Optic Nerve; Optic Nerve Diseases; Paranasal Sinus Neoplasms; Radiation Injuries; Radiotherapy; Visual Fields; Warfarin | 2004 |
Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma.
Topics: Biomarkers, Tumor; Cerebellar Ataxia; Cerebellum; Disease Progression; Dose-Response Relationship, Drug; Esthesioneuroblastoma, Olfactory; Ethmoid Sinus; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Nasal Septum; Oculomotor Muscles; Opsoclonus-Myoclonus Syndrome; Paranasal Sinus Neoplasms; Remission Induction; Skin Neoplasms; Treatment Outcome | 2008 |